Design of Biomedical Devices-Class 10
Design of Biomedical Devices-Class 10
Biomedical
Devices
Module 3-Class-11 Design Verification,
Product validation and Design Transfer
Product Development
• A product development process ensures that the design, development, and transfer of a new
or modified medical device will result in a product that is safe, effective, and meets user
needs and intended use requirements. As shown in Figure 6.1, design controls begin with the
approval of product requirements. Product requirements include the needs of the users and
patients and intended use of the device. A design and development plan is developed to
describe the design and development activities. The product requirements are converted
into technical design inputs (System Requirements Specification) that serve as a basis for the
design of a medical device. Iterations of the design process result in design outputs that are
verified against the design inputs to ensure that the design outputs adequately address the
technical design inputs. The finished device is validated to ensure that all product
requirements have been addressed. Final product and process specifications are transferred
to production. In the course of the design process, documentation pertaining to the design
of the finished device is maintained in a design history file (DHF). Changes to the device
design are managed and controlled both prior to and after design transfer until retirement.
Risk management is performed simultaneously with device design and development. Formal
design reviews are conducted at appropriate points to evaluate the adequacy of the design
to fulfill all requirements.
6.1 PRODUCT REQUIREMENTS
The product concept must be documented. This can range from a brief description
for products similar to existing ones to a formal document, such as a marketing
requirements document, for new and complex products.Product requirements
include the needs of the users and patients and address the intended use of the
device. They also include the following requirements, if applicable:
• User/patient/clinical performance characteristics,• Privacy and security,• Safety,•
Regulatory,• Quality, •Reliability, Compatibility with accessories/auxiliary devices or
products Compatibility with the intended environment,• Human factors,• Physical
characteristics,• Sterility, Manufacturability,• Serviceability,• Labeling, packaging,
storage,• Requirements for intended markets (domestic or international)
The types of information described may come from a variety of sources such as
market research studies, customer complaints, field failure analysis, service records,
regulatory needs, user interviews, and customer satisfaction analysis. Input sources
used shall be documented. Requirements that are essential to the quality, safety,
and proper function must be identified. Product requirements are reviewed,
approved, and documented in the DHF.
6.2 DESIGN AND DEVELOPMENT PLANNING
• Each product program must establish and maintain a plan(s) that
describes or references the design and development activities and defines
responsibility for implementation. It identifies and describes the
interfaces with different groups or activities that provide, or result in,
input to the design and development process. The design and
development plan is reviewed, updated, and approved as the design and
development of a product evolves. The design and development plan
describes how the different design control requirements are to be met. It
includes all major activities, design deliverables, responsibilities,
resources, and associated timelines for the development of a product.
The program team creates the design and development plan and reviews,
updates, and approves the plan as design and development evolves. The
design and development plan resides in the DHF, and any changes made
to the plan also reside in the DHF.
• 6.2.1 Design and Development Plan
• The following elements are addressed, if applicable, in the design and development
plan. The applicability of these elements is determined by the program team, and
justification is provided for elements deemed not applicable.
• 6.2.1.1 Program Goals
• High-level goals and objectives of the product are described, that is, what is to be
developed and other considerations that communicate the size, scope, and complexity
of the product development project.
• 6.2.1.2 Design and Development Elements
• Design and development elements refer to different categories of activities performed
in the design of a medical device from design inputs through design transfer to
manufacturing and service. The design and development plan describes the different
elements including their scope and planned approach to fulfill the requirements of
each element. The timelines for the activities associated with the different elements
are incorporated in the design and development schedule. Required design and
development elements include the following:
• 6.2.1.3 Organizational and Key Interfaces
• Identify the key individuals/functions responsible for performing the design and development
tasks,including cross-functional program team members and external resources, such as suppliers,
contractors,or partners. At a minimum, define the roles for research and development (R & D),
marketing,manufacturing, quality, reliability, regulatory, and service.
• 6.2.1.4 Deliverables and Responsibilities
• Identify the design control deliverables for the product program and indicate the personnel responsible
for completing them. The deliverables to be addressed are dependent on the size, scope, and complexity
of the product program and must be defined by the program team leader and program team.
• 6.2.1.5 Design and Development Schedule
• Based on the size, scope, complexity of the product program, the design and development elements,and
the list of deliverables, prepare a design and development schedule. The schedule is specified at the level
of detail necessary for carrying out major activities, completing program deliverables,and addressing
design control requirements. Identify these activities, deliverables, the responsible individual/function,
resources required, and the associated due dates. Indicate which activities are concurrent, sequential,
and dependent on other activities. Identify the major milestones and formal design reviews.
• 6.2.1.6 Approval of Design and Development Plan
• The plan is completed and approved by the program team prior to the commencement of detailed
design.
• 6.2.1.7 Incorporation of Updates to Design and Development Plan
• Changes to the design and development plan are reviewed and approved at key milestones as
determined by the program team. The design and development plan identifies the number and timing of
• 6.3 SYSTEM REQUIREMENTS SPECIFICATION
Product requirements are translated into the system requirements specification that specifies what the design must do to an
engineering level of detail. Inputs from results of risk management are included.
• The system requirements specification includes the following types of requirements:
• Functional requirements: these requirements specify what the device does, focusing on the operational capabilities of the
device and processing of inputs and the resultant outputs.
• Physical and performance requirements: these requirements specify how much or how well the design must perform,
addressing such issues as speed, strength, size, weight, response times, accuracy, precision, limits of operation, device safety,
reliability, and so forth.
• Interface requirements: these requirements specify characteristics that are critical to compatibility with external systems
(including user and/or patient interface).
• System architecture: these requirements specify relationships among logical functions,physical systems/subsystems, and
interfaces.
• Software requirements (if applicable): these requirements specify product functionality to be implemented through software
and the functional, performance, interface, and safety requirements for the software subsystem(s).
Where appropriate, the system requirements specification should include additional design details in areas such as
specification limits and tolerance, risk management, toxicity and biocompatibility, electromagnetic compatibility (EMC),
human factors, software, chemical characteristics, reliability,regulatory requirements, manufacturing processes, service
design requirements, and testing. If the design logically decomposes into subsystems, the system requirements specification
may be used to generate subsystem-level requirements. Traceability of the system requirements specification to product
requirements and design outputs is maintained. Requirements that are essential to quality, safety, and proper function are
identified. Incomplete, ambiguous, or conflicting requirements are identified and resolved using the following mechanism:
• The program team reviews design inputs to identify and resolve incomplete, ambiguous,or conflicting requirements.
• Any remaining incomplete, ambiguous, or conflicting requirements are addressed in a formal design review.
The system requirements specification is reviewed, approved, and documented in the DHF.
• 6.4 DESIGN INPUT
• Each product program must establish design inputs to ensure that design requirements relating to a device are appropriate and
address the intended use of the device, including the needs of the user and patient. There should be a mechanism for addressing
incomplete, ambiguous, or conflicting requirements. The design input requirements are documented, reviewed, and approved by a
designated individual(s). The approval, including the date and signature of the individual(s) approving the requirements, is
documented.
• Each product program establishes product requirements. Product requirements include the needs of the users and patients and
intended use of the device. Product requirements are translated into technical design inputs that are specified at an engineering
level of detail.
• Product requirements and the system requirements specification obtained from the translation of product requirements constitute
design input for the product program. Traceability is maintained to ensure that product requirements are linked to the
corresponding system requirements specification and design outputs.
• 6.4.1 Product Requirements
• The product concept is documented, and the higher-level product requirement is codified. This can range from a brief description
for products similar to existing ones to a formal document, such as a marketing requirements document, for new and complex
products. Product requirements include the needs of the users and patients and address the intended use of the device.
• They also include the following requirements, if applicable:
• User/patient/clinical performance characteristics,• Privacy and security,• Safety,• Regulatory,• Quality,• Reliability,• Compatibility
with accessories/auxiliary devices or products,• Compatibility with the intended environment,• Human factors,• Physical
characteristics,• Sterility,• Manufacturability,• Serviceability,• Labeling, packaging, storage,• Requirements for intended markets
(domestic or international)
• The types of information described above may come from a variety of sources such as market research studies, customer
complaints, field failure analysis, service records, regulatory needs, user interviews, and customer satisfaction analysis. Input
sources used are documented. Requirements that are essential to quality, safety, and proper function are identified. Product
requirements are reviewed, approved, and documented in the DHF.
• 6.5 DESIGN OUTPUT
Design outputs are the results of the design effort. Initial design activities result in
intermediate design outputs. As design and development progresses, intermediate
design outputs evolve into final design outputs that form the basis of the device
master record (DMR).
• 6.5.1 Intermediate Design Output
• Intermediate design outputs are deliverables that define and characterize the design.
The following intermediate design outputs are created and recorded in the DHF as
applicable:
• Preliminary design specifications
• Models and prototypes
• Software source code
• Risk analysis results
• Traceability documents
• Biocompatibility and bioburden test results
• Other intermediate design outputs as appropriate
• 6.5.2 Final Design Output
• Final design outputs form the basis of the DMR, are recorded in the DHF, and shall include the
following elements:
• Device specifications
• Device drawings
• Component
• Assembly
• Finished device
• Composition, formulation, component specifications
• Subassembly specifications (if applicable)
• Component and material specifications
• Product configuration documents
• Parts list
• Bill of materials
• Software specifications (if applicable)
• Software machine code, such as a diskette or master EPROM
• Production process specifications
6.5.2 Final Design Output-contd…
Test methods are based on generally acceptable practices for the technologies employed in similar
products, such as compendia methods (standardized methods)(e.g., American Society for Testing
Materials [ASTM], International Electrotechnical Commission [IEC], Institute of Electrical and
Electronic Engineers [IEEE], National Institute of Standards and Technology [NIST]). Test methods
include defined conditions for testing. The test equipment used for verification must be
calibrated and controlled according to quality system requirements. Repeatability and
reproducibility of test procedures are determined. Technical comments about any deviations or
other events that occur during testing shall be documented.
4. Validation Testing:
a.Execution and b.Data collection.
7. Post-Validation Activities:
a.Corrective actions and b.Documentation update.